Samir Gharib
Director of Finance/CFO at SPRUCE BIOSCIENCES, INC.
Net worth: 150 257 $ as of 31/05/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Grey | M | 71 | 7 years | |
| Dan Spiegelman | M | 65 | 4 years | |
| Tiba Aynechi | M | 48 | 8 years | |
| Kirk Ways | M | 72 | 3 years | |
| Niall O'Donnell | M | 51 | 8 years | |
| Julian Gangolli | M | 66 | 8 years | |
| Percival Barretto-Ko | M | 51 | 1 years | |
| Bali Muralidhar | M | 44 | 4 years | |
| Camilla Simpson | F | 52 | 7 years | |
| Javier Szwarcberg | M | 54 | 2 years | |
| Elizabeth Weatherman | F | 64 |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | 11 years |
| SAba Sile | M | - | 2 years | |
| Azita Nejad | F | - | 10 years | |
| Ralph Charlton | M | 54 | 2 years | |
| Libbie Mansell | M | - | 2 years | |
| P. J. Ramtin | F | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Steven R. Deitcher | M | 59 |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | 6 years |
| James Walter Glasheen | M | 56 | 12 years | |
| Robert Spiegel | M | 73 |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | 3 years |
| Philip Vickers | M | 64 | 8 years | |
| Vincent Carey | M | - |
Haas School of Business
| 13 years |
| Ron Wooten | M | 64 | - | |
| Dina Chaya | M | 52 | 3 years | |
| Pamela Wedel | F | - | - | |
| Cyril Allouche | M | 52 | 2 years | |
| Richard A. King | M | 59 | 2 years | |
| Jacob M. Waugh | M | 53 | 16 years | |
| Mark Prygocki | M | 58 | 3 years | |
| Vicente Trelles | M | 68 | - | |
| Jonas Karl Hansson | M | 50 | - | |
| Jeanie D. Herbert | F | - | 6 years | |
| Tyler Marshall Nielsen | M | - |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | - |
| Abhay Joshi | M | 61 | 7 years | |
| Jonathan Crane Hudacko | M | - |
Haas School of Business
| 2 years |
| Mukul Agarwal | M | - | 3 years | |
| Christian Fuentes | M | - |
Haas School of Business
| 2 years |
| Iwao Yoshino | M | 56 |
Haas School of Business
| 2 years |
| Dennis Wee | M | - |
Haas School of Business
| 4 years |
| Brian Keith Miller | M | - |
Haas School of Business
| 2 years |
| Mary A. Francis | F | 59 |
Haas School of Business
| 2 years |
| Patty Perla | F | - | - | |
| Justin Ford | M | - | 6 years | |
| Jim Bobowski | M | - |
Haas School of Business
| 2 years |
| Yu Ben Meng | M | - |
Haas School of Business
| 1 years |
| Jessica Lee | F | - |
Haas School of Business
| 4 years |
| Scott Williamson | M | - |
Haas School of Business
| 2 years |
| Sunil Chokshi | M | - |
Haas School of Business
| 4 years |
| Parizad Parchi | F | 44 |
Haas School of Business
| 4 years |
| Rafa Alenda | M | - |
Haas School of Business
| 2 years |
| Selim Giray | M | - |
Haas School of Business
| 2 years |
| Brent Wu | M | - |
Haas School of Business
| 2 years |
| Shuhong Ye | M | 51 |
Haas School of Business
| 3 years |
| Richard Chan Chan | M | - |
Haas School of Business
| 2 years |
| Matt Hively | M | - |
Haas School of Business
| 4 years |
| Kevin Lin | M | - |
Haas School of Business
| 1 years |
| Crystal Matthews | F | - |
Haas School of Business
| 4 years |
| Chad Oh | M | 66 | 1 years | |
| HoChan Lee | M | - |
Haas School of Business
| 2 years |
| Sung An | M | - |
Haas School of Business
| 2 years |
| Shingo Omura | M | - |
Haas School of Business
| 2 years |
| Christian Urazan Ramirez | M | - |
Haas School of Business
| 2 years |
| John Wong | M | - |
Haas School of Business
| 2 years |
| Michael Ngok Fung Im | M | - |
Haas School of Business
| 4 years |
| Daniel H. Cheng | M | - |
Haas School of Business
| 4 years |
| Gabriel Kra | M | - |
Haas School of Business
| 1 years |
| Terry A. Marsh | M | - |
Haas School of Business
| - |
| Brett Wilson | M | 50 |
Haas School of Business
| 2 years |
| John Hughes | M | 46 |
Haas School of Business
| 2 years |
| Ayush Singhania | M | - |
Haas School of Business
| 4 years |
| Li Yong Dong | M | 53 |
Haas School of Business
| 2 years |
| John Coelho | M | - |
Haas School of Business
| 2 years |
| David Su | M | - |
Haas School of Business
| 4 years |
| Hong Bo Lu | M | 53 |
Haas School of Business
| 2 years |
| Arthur Peter Bertolino | M | 69 | 2 years | |
| Maulik Bhansali | M | - |
Haas School of Business
| 1 years |
| Steve Schuman | M | - |
Haas School of Business
| 2 years |
| Luiz Guilherme Sauerbronn | M | - |
Haas School of Business
| 2 years |
| Brian Alan Krawez | M | - |
Haas School of Business
| 2 years |
| Michael Dance | M | 67 |
Haas School of Business
| - |
| Howard H. Pien | M | 66 |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | 1 years |
| Andrew Seligson | M | - |
Haas School of Business
| 2 years |
| Pavel Danilin | M | 48 |
Haas School of Business
| 2 years |
| Ongki Kurniawan | M | 52 |
Haas School of Business
| 2 years |
| Josh Elman | M | - |
Haas School of Business
| 1 years |
| Jim E. Quinn | M | - |
Haas School of Business
| 1 years |
| Hitoshi Koide | M | 55 |
Haas School of Business
| 2 years |
| Irina Tagintseva | F | - |
Haas School of Business
| 4 years |
| Matthew Ricardo Segura | M | - |
Haas School of Business
| 4 years |
| Roger Siboni | M | 68 |
Haas School of Business
| 9 years |
| Geoff Karren | M | - |
Haas School of Business
| 2 years |
| Ravi Anaparti | M | - |
Haas School of Business
| 2 years |
| Gavin Bates | M | - |
Haas School of Business
| 2 years |
| Abhishek Bhutra | M | - |
Haas School of Business
| 1 years |
| Anthony James Brekke | M | - |
Haas School of Business
| 2 years |
| Sebastien Mehdi Boifort | M | - |
Haas School of Business
| 2 years |
| Jonathan Zabusky | M | 50 |
Haas School of Business
| 2 years |
| Sharon Broadston Hall | F | 60 | 8 years | |
| Inderpreet Singh Wadhwa | M | 51 |
Haas School of Business
| 4 years |
| Dawn Belt | F | - |
Haas School of Business
| 2 years |
| Adrian Garcia | M | - |
Haas School of Business
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Samir Gharib
- Personal Network
